Table 3

Results of anthropometric measurements. Group (mean, 95% CI)

MeasurementASC (n=22)GTPS (n=27)GTR (n=30)OA (n=20)ANOVA (p values)
BMI (kgm−2)25.0 (23.5 to 26.5)27.5 (25.4 to 29.6)26.8 (25.2 to 28.4)25.3 (23.5 to 27.1)0.154
Waist girth (cm) (W)83.0 (78.9 to 87.1)88.4 (82.9 to 93.9)84.6 (79.6 to 89.6)84.0 (79.0 to 89.0)0.420
Hip girth (cm) (H)102.8 (99.4 to 106.2)109.1 (104.9 to 113.2)105.9 (100.0 to 109.2)104.2 (100.0 to 108.4)0.090
GT girth (cm (GTg))99.1 (94.7 to 103.5)105.9 (100.2 to 111.6)103.8 (100.3 to 107.3)100.3 (96.7 to 103.9)0.036*
W:H0.81 (0.783 to 0.837)0.79 (0.753 to 0.827)0.80 (0.764 to 0.836)0.81 (0.781 to 0.839)0.884
W:GTg0.85 (0.791 to 0.909)0.84 (0.797 to 0.883)0.82 (0.772 to 0.868)0.84 (0.791 to 0.886)0.855
  • ACS, asymptomatic control group; ANOVA, analysis of variance; BMI, body mass index; GTg, greater trochanter girth; GTPS, greater trochanteric pain syndrome group; GTR, gluteal tendon reconstruction group; H, hip girth; OA, hip osteoarthritis group; W, waist girth.

  • * Posthoc analysis showed a trend for the GTPS group to be larger about the greater trochanters than the ASC group, but pair wise analyses failed to demonstrate group differences, p=0.079. None of the other measures approached significance.